These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30501688)

  • 21. [CD96 expression on bone marrow mononuclear cells in 91 patients with acute leukemia].
    Wu Y; Xiao M; Zhu L; Zhou XX; Gong Q; Xin X; Li CR; Zhou JF; Deng JN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):585-8. PubMed ID: 21729528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia.
    Arai N; Homma M; Abe M; Baba Y; Murai S; Watanuki M; Kawaguchi Y; Fujiwara S; Kabasawa N; Tsukamoto H; Uto Y; Ariizumi H; Yanagisawa K; Hattori N; Saito B; Shiozawa E; Harada H; Yamochi-Onizuka T; Nakamaki T; Takimoto M
    Int J Hematol; 2019 May; 109(5):539-544. PubMed ID: 30847774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
    Aref S; Azmy E; El Ghannam D; Haroun M; Ibrahim L; Sabry M
    Cancer Biomark; 2020; 29(1):9-16. PubMed ID: 32417762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of CD44, CD87 and CD123 in Acute Leukemia and Its Correlation with Cellular Immunity].
    Wang SW; Yao HX; Rao R; Xia MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1794-1798. PubMed ID: 31839040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic Significance of the Percentage of Blasts with CD34
    Xiang LL; Qiu GQ; Xie XB; Cen JN; Hu SY; Gu WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):61-65. PubMed ID: 28245376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
    Bras AE; de Haas V; van Stigt A; Jongen-Lavrencic M; Beverloo HB; Te Marvelde JG; Zwaan CM; van Dongen JJM; Leusen JHW; van der Velden VHJ
    Cytometry B Clin Cytom; 2019 Mar; 96(2):134-142. PubMed ID: 30450744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and Significance of PD-1, TIM-3 and VISTA on T Cell of Acute Myeloid Leukemia Patients].
    Ge MJ; Xu KL; Xu T; Tang YN; Li ZY; Yan ZL; Sun HY; Cheng H; Zhu F; Sang W; Huang YH; Qiu TT; Li DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):748-752. PubMed ID: 32552931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
    Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
    [No Abstract]   [Full Text] [Related]  

  • 33. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.
    Hosen N; Park CY; Tatsumi N; Oji Y; Sugiyama H; Gramatzki M; Krensky AM; Weissman IL
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11008-13. PubMed ID: 17576927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
    Lamble AJ; Eidenschink Brodersen L; Alonzo TA; Wang J; Pardo L; Sung L; Cooper TM; Kolb EA; Aplenc R; Tasian SK; Loken MR; Meshinchi S
    J Clin Oncol; 2022 Jan; 40(3):252-261. PubMed ID: 34855461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cluster of differentiation 96 as a leukemia stem cell-specific marker and a factor for prognosis evaluation in leukemia.
    DU W; Hu Y; Lu C; Li J; Liu W; He Y; Wang P; Cheng C; Hu YU; Huang S; Yao J; Zheng J
    Mol Clin Oncol; 2015 Jul; 3(4):833-838. PubMed ID: 26171191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
    Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
    Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD123 redirected multiple virus-specific T cells for acute myeloid leukemia.
    Zhou L; Liu X; Wang X; Sun Z; Song XT
    Leuk Res; 2016 Feb; 41():76-84. PubMed ID: 26740053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML.
    Das N; Gupta R; Gupta SK; Bakhshi S; Malhotra A; Rai S; Singh S; Prajapati VK; Sahoo RK; Gogia A; Sharma A; Kumar L
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e673-e684. PubMed ID: 32561191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.